Prosecution Insights
Last updated: November 04, 2026

Xeno Cell Innovations S R O

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Xeno Cell Innovations S R O maintains a focused presence in the Biotechnology & Pharmaceuticals technology area. The current prosecution profile is defined by 1 pending office action, representing the total active dialogue with the patent office. This specific matter is assigned to CLOW, LORI A, who serves as the busiest examiner for the portfolio. The emphasis on this sector indicates a specialized research and development focus.

The data reflects a singular point of contact within the USPTO, as the company is working with 1 distinct examiner across a distinct art unit. With CLOW, LORI A overseeing the busiest examiner pending action, the firm's immediate patenting success relies on the examination style of a single official. This lack of distribution across different art units or examiners means that the company faces a consolidated set of procedural expectations. For a practitioner, this indicates that the current prosecution strategy is entirely focused on a single technical niche and the specific interpretation of the Biotechnology & Pharmaceuticals field.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CLOW, LORI A 1 64.2% +28.6%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17268340 BIOLOGICAL COMPUTING SYSTEMS AND METHODS FOR MULTIVARIATE SURFACE ANALYSIS AND OBJECT DETECTION CLOW, LORI A 49d overdue

Top Art Units

Art UnitApps
1687 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17268340 BIOLOGICAL COMPUTING SYSTEMS AND METHODS FOR MULTIVARIATE SURFACE ANALYSIS AND OBJECT DETECTION CLOW, LORI A 1687 §103 Non-Final OA 49d overdue Pending Feb 12, 2021

Managing Xeno Cell Innovations S R O's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Xeno Cell Innovations S R O have?

Xeno Cell Innovations S R O has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Xeno Cell Innovations S R O applications?

Lori A Clow has the most, with 1 of Xeno Cell Innovations S R O's pending office actions.

What technology area are Xeno Cell Innovations S R O's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month